melanoma and other skin tumours Ipilimumab (IPI) vs placebo (PBO) after complete resection of stage III melanoma: final overall survival results from the EORTC 18071 randomized, double-blind, phase 3 trial
Journal article published in 2016 by
A. M. M. Eggermont,
V. Chiarion-Sileni 
,
J.-J. Grob,
R. Dummer,
J. D. Wolchok,
H. Schmidt,
O. Hamid,
C. Robert,
P. A. Ascierto,
J. M. Richards,
C. Lebbé,
V. Ferraresi,
M. Smylie,
J. S. Weber,
C. Taitt
and other authors.
,
J.-J. Grob,
R. Dummer,
J. D. Wolchok,
H. Schmidt,
O. Hamid,
C. Robert,
P. A. Ascierto,
J. M. Richards,
C. Lebbé,
V. Ferraresi,
M. Smylie,
J. S. Weber,
C. Taitt
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 